Howard E. Greenberg
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Antibiotics Pharmacokinetics and Efficacy
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Inflammatory mediators and NSAID effects 9
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Statistical Methods in Clinical Trials 5
- Co-authors
- Scott Arthur Waldman (22 shared papers)Walter K. Kraft (15 shared papers)Paul Deutsch (5 shared papers)Lisa P. Gillen (6 shared papers)Michael Hesney (3 shared papers)Robert B. Case (1 shared paper)Julie A. Stone (3 shared papers)Charles Noah Bernstein (4 shared papers)
- Journals
- The Journal of Clinical Pharmacology (22 papers)Antimicrobial Agents and Chemotherapy (5 papers)Therapeutic Innovation & Regulatory Science (4 papers)The American Journal of Gastroenterology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Howard E. Greenberg
64 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 142
- Pharmacology 344
- Pharmacology 473
- Infectious Diseases 477
- Applied Microbiology and Biotechnology 37
- Molecular Medicine 80
Countries citing papers authored by Howard E. Greenberg
This map shows the geographic impact of Howard E. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard E. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard E. Greenberg more than expected).
Fields of papers citing papers by Howard E. Greenberg
This network shows the impact of papers produced by Howard E. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard E. Greenberg. The network helps show where Howard E. Greenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard E. Greenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 222 | |
| 2 | 2002 | 136 | |
| 3 | 2003 | 130 | |
| 4 | 2001 | 107 | |
| 5 | 2009 | 103 | |
| 6 | 2006 | 87 | |
| 7 | 2005 | 86 | |
| 8 | 2004 | 85 | |
| 9 | 2009 | 80 | |
| 10 | 2003 | 78 | |
| 11 | 2003 | 76 | |
| 12 | 1975 | 65 | |
| 13 | A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. | 2000 | 63 |
| 14 | 1976 | 60 | |
| 15 | 2008 | 59 | |
| 16 | 2003 | 56 | |
| 17 | 2010 | 49 | |
| 18 | 2007 | 44 | |
| 19 | 1997 | 44 | |
| 20 | 2012 | 42 |
About Howard E. Greenberg
Howard E. Greenberg is a scholar working on Pharmacology, Pharmacology, Statistics and Probability, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 65 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Inflammatory mediators and NSAID effects (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Statistical Methods in Clinical Trials (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Pharmacology (344 citations), Pharmacology (473 citations), Infectious Diseases (477 citations), Applied Microbiology and Biotechnology (37 citations) and Molecular Medicine (80 citations). Howard E. Greenberg has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Scott Arthur Waldman, Walter K. Kraft, Paul Deutsch, Lisa P. Gillen, Michael Hesney, Robert B. Case, Julie A. Stone, Charles Noah Bernstein, Keith M Gottesdiener and Gregory A. Winchell. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Therapeutic Innovation & Regulatory Science, The American Journal of Gastroenterology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.